An education campaign about hormone replacement therapy has been launched by the FDA (Food and Drug Administration) in the United States following the Women’s Health Initiative study that was stopped in July 2002 when it was seen that the therapy increased the risk of breast cancer, stroke an cardiovascular disease.
Food and Drug Administration
A menopause and HRT fact sheet will be made available from the National Women’s Health Information Centre at
The BBC reports that the European Agency for the Evaluation of Medicinal Products (EMEA) has launched an investigation into the safety of HRT. The investigation has been set up after the results of the ‘Million Women Study’ were published in the Lancet recently (Lancet 2003 362:419-27 and 414-5). The study found that women who used particular types of HRT long term had double the risk of breast cancer.
European Agency for the Evaluation of Medical Products